Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation

Clade C HIV-1 envelope vaccination regimens differ in their ability to elicit antibodies with moderate neutralization breadth against genetically diverse tier 2 HIV-1 envelope variants

(2019) Samantha Burton et al.   JOURNAL OF VIROLOGY

Viral metagenomics revealed novel betatorquevirus species in pediatric inpatients with encephalitis/meningoencephalitis from Ghana

(2019) Daniel Eibach et al.   Scientific Reports

Prime boost immunisations with DNA, MVA and protein-based vaccines elicit robust HIV-1, Tier 2 neutralizing antibodies against the CAP256 superinfecting virus.

(2019) Michiel T van Diepen et al.   JOURNAL OF VIROLOGY

Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs

(2018) Christine A. Bricault et al.   JOURNAL OF VIROLOGY

Role of BK polyomavirus (BKV) and Torque teno virus (TTV) in liver transplant recipients with renal impairment

(2018) Anke Herrmann et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Possible risks posed by single-stranded DNA viruses of pigs associated with xenotransplantation

(2018) Anbu K. Karuppannan et al.   XENOTRANSPLANTATION

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256

(2018) Michiel T. van Diepen et al.   PLoS One

Current views on the potential for development of a HIV vaccine

(2017) Kristen W. Cohen et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Xenogenic rolling-circle replication of a synthetic beak and feather disease virus genomic clone in 293TT mammalian cells and Nicotiana benthamiana

(2017) Guy L. Regnard et al.   JOURNAL OF GENERAL VIROLOGY

Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys

(2017) Boris Julg et al.   JOURNAL OF VIROLOGY

DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies

(2017) Gerald K. Chege et al.   VACCINE

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice

(2017) Ros Chapman et al.   PLoS One

Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap

(2016) Glenda E. Gray et al.   Clinical and Vaccine Immunology

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

(2016) Benedikt Asbach et al.   JOURNAL OF VIROLOGY

Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition

(2016) Sultan Abdul-Jawad et al.   MOLECULAR THERAPY

Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants

(2016) Gavin Churchyard et al.   PLoS One

Justification for the inclusion of Gag in HIV vaccine candidates

(2015) Anna-Lise Williamson et al.   Expert Review of Vaccines

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

(2015) Jean-Charles Nault et al.   NATURE GENETICS

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies

(2015) Jinal N Bhiman et al.   NATURE MEDICINE

Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

(2013) Dan H. Barouch et al.   CELL

Complex Correlates of Protection After Vaccination

(2013) S. A. Plotkin   CLINICAL INFECTIOUS DISEASES

Multiple Pathways of Escape from HIV Broadly Cross-Neutralizing V2-Dependent Antibodies

(2013) P. L. Moore et al.   JOURNAL OF VIROLOGY

Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine,Rotarix™

(2013) Gary Dubin et al.   Human Vaccines & Immunotherapeutics

Investigation of porcine circovirus contamination in human vaccines

(2012) Sarah M. Gilliland et al.   BIOLOGICALS

Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

(2012) Lucy W. Barrett et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine

(2012) Michael Hellerstein et al.   Human Vaccines & Immunotherapeutics

Correction: Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression

(2011) Stephan Fath et al.   PLoS One

Productive infection of human hepatocellular carcinoma cells by porcine circovirus type 1

(2011) Nathan M. Beach et al.   VACCINE

The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine

(2011) Fiona L Tanzer et al.   Virology Journal

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys

(2010) Dan H Barouch et al.   NATURE MEDICINE

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys

(2010) Sampa Santra et al.   NATURE MEDICINE

ORF3 of porcine circovirus 2 enhances the in vitro and in vivo spread of the of the virus

(2010) Anbu K. Karuppannan et al.   VIROLOGY

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

(2009) Ann J Hessell et al.   NATURE MEDICINE

High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector

(2009) Guy L. Regnard et al.   PLANT BIOTECHNOLOGY JOURNAL

A Multigene HIV Type 1 Subtype C Modified Vaccinia Ankara (MVA) Vaccine Efficiently Boosts Immune Responses to a DNA Vaccine in Mice

(2008) Enid Shephard et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses

(2008) Shakuntala Megati et al.   VACCINE